Use este identificador para citar ou linkar para este item:
http://www.repositorio.ufop.br/jspui/handle/123456789/14249
Título: | New heteroleptic RuII/diphosphine complexes with cytotoxicity against human breast and murine ascitic sarcoma 180 tumor cells. |
Autor(es): | Lima, Benedicto Augusto Vieira Correa, Rodrigo de Souza Graminha, Angelica Ellen Varela Júnior, Jaldyr de Jesus Gomes Silva, Albérico Borges Ferreira da Ellena, Javier Alcides Silva, Thales E. M. Batista, Alzir Azevedo |
Palavras-chave: | Picolinate Biphosphines |
Data do documento: | 2020 |
Referência: | LIMA, B. A. V. et al. New heteroleptic RuII/diphosphine complexes with cytotoxicity against human breast and murine ascitic sarcoma 180 tumor cells. Journal of the Brazilian Chemical Society, v. 31, n. 7, p. 1352-1361, 2020. Disponível em: <http://static.sites.sbq.org.br/jbcs.sbq.org.br/pdf/2019-0506AR.pdf>. Acesso em: 10 jun. 2021. |
Resumo: | The preparation, characterization, theoretical calculations and biological application of four RuII complexes with 2-picolinate (pic), 2,2’-bipyridine (bipy) and P-P as ligands [P-P = 1,1-bis(diphenylphosphino)methane (dppm-1), 1,2-bis(diphenylphosphino)ethane (dppe-2), 1,3-bis(diphenylphosphino)propane (dppp-3) or 1,1’-bis(diphenylphosphino)ferrocene (dppf-4)], is here presented. The complexes 1-4, with general formula [Ru(pic)(P-P)(bipy)]PF6, were characterized by elemental analysis and by infrared (IR), UV-Vis, nuclear magnetic resonance (NMR 1 H and 13P{1 H}) spectroscopies, cyclic voltammetry and X-ray crystallography technique. Additionally, preliminary in vitro tests against human breast (MDA-MB-231) and murine ascitic sarcoma 180 (S180) tumor cell lines were carried out, and compared with cisplatin, a reference drug. The drug concentration at which 50% of the cells are viable relative to the control (IC50) values found for complexes 1, 2, 3 and 4 against MDA-MB-231 tumor cells were around 14.6, 7.6, 3.3 and 0.4 μM, respectively, while against S180 tumor cells these complexes showed IC50 values of 71.9, 31.3, 11.2 and 3.5 μM, respectively. Therefore, the complexes were more active against MDA-MB-231 than S180. |
URI: | http://www.repositorio.ufop.br/jspui/handle/123456789/14249 |
DOI: | http://dx.doi.org/10.21577/0103-5053.20200020 |
ISSN: | 1678-4790 |
Licença: | This is an open-access article distributed under the terms of the Creative Commons Attribution License. Fonte: o PDF do artigo. |
Aparece nas coleções: | DEQUI - Artigos publicados em periódicos |
Arquivos associados a este item:
Arquivo | Descrição | Tamanho | Formato | |
---|---|---|---|---|
ARTIGO_NewHeterolepticDiphosphine.pdf Restricted Access | 950,61 kB | Adobe PDF | Visualizar/Abrir |
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.